Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Death Dis ; 11(5): 308, 2020 05 04.
Artigo em Inglês | MEDLINE | ID: mdl-32366831

RESUMO

Caspase-2, -9, and -3 are reported to control myoblast differentiation into myotubes. This had been previously explained by phosphatidylserine exposure on apoptotic myoblasts inducing differentiation in neighboring cells. Here we show for the first time that caspase-3 is activated in the myoblasts undergoing differentiation. Using RNAi, we also demonstrate that differentiation requires both cytochrome c and Apaf-1, and by using a new pharmacological approach, we show that apoptosome formation is required. We also show that Bid, whose cleavage links caspase-2 to the mitochondrial death pathway, was required for differentiation, and that the caspase cleavage product, tBid, was generated during differentiation. Taken together, these data suggest that myoblast differentiation requires caspase-2 activation of the mitochondrial death pathway, and that this occurs in the cells that differentiate. Our data also reveal a hierarchy of caspases in differentiation with caspase-2 upstream of apoptosome activation, and exerting a more profound control of differentiation, while caspases downstream of the apoptosome primarily control cell fusion.


Assuntos
Apoptossomas/metabolismo , Caspase 3/metabolismo , Diferenciação Celular , Fibras Musculares Esqueléticas/metabolismo , Mioblastos/citologia , Mioblastos/enzimologia , Animais , Apoptose/efeitos dos fármacos , Apoptossomas/efeitos dos fármacos , Fator Apoptótico 1 Ativador de Proteases/metabolismo , Proteína Agonista de Morte Celular de Domínio Interatuante com BH3/metabolismo , Caspase 2/metabolismo , Inibidores de Caspase/farmacologia , Diferenciação Celular/efeitos dos fármacos , Fusão Celular , Linhagem Celular , Cicloexanonas/farmacologia , Citocromos c/metabolismo , Ativação Enzimática/efeitos dos fármacos , Técnicas de Silenciamento de Genes , Humanos , Camundongos , Fibras Musculares Esqueléticas/efeitos dos fármacos , Mioblastos/efeitos dos fármacos , RNA Interferente Pequeno/metabolismo
2.
FEBS Open Bio ; 9(7): 1194-1203, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31033240

RESUMO

The expense and time required for in vivo reproductive and developmental toxicity studies have driven the development of in vitro alternatives. Here, we used a new in vitro split luciferase-based assay to screen a library of 177 toxicants for inhibitors of apoptosome formation. The apoptosome contains seven Apoptotic Protease-Activating Factor-1 (Apaf-1) molecules and induces cell death by activating caspase-9. Apaf-1-dependent caspase activation also plays an important role in CNS development and spermatogenesis. In the in vitro assay, Apaf-1 fused to an N-terminal fragment of luciferase binds to Apaf-1 fused to a C-terminal fragment of luciferase and reconstitutes luciferase activity. Our assay indicated that pentachlorophenol (PCP) inhibits apoptosome formation, and further investigation revealed that PCP binds to cytochrome c. PCP is a wood preservative that reduces male fertility by ill-defined mechanisms. Although the data show that PCP inhibited apoptosome formation, the concentration required suggests that other mechanisms may be more important for PCP's effects on spermatogenesis. Nonetheless, the data demonstrate the utility of the new assay in identifying apoptosome inhibitors, and we suggest that the assay may be useful in screening for reproductive and developmental toxicants.


Assuntos
Apoptossomas/efeitos dos fármacos , Pentaclorofenol/toxicidade , Testes de Toxicidade/métodos , Apoptose/efeitos dos fármacos , Apoptossomas/metabolismo , Fator Apoptótico 1 Ativador de Proteases/metabolismo , Morte Celular , Citocromos c/metabolismo , Células HEK293 , Humanos , Luciferases/metabolismo , Pentaclorofenol/farmacologia , Transdução de Sinais , Bibliotecas de Moléculas Pequenas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...